SE9402816D0 - Method and meams for drug administration - Google Patents

Method and meams for drug administration

Info

Publication number
SE9402816D0
SE9402816D0 SE9402816A SE9402816A SE9402816D0 SE 9402816 D0 SE9402816 D0 SE 9402816D0 SE 9402816 A SE9402816 A SE 9402816A SE 9402816 A SE9402816 A SE 9402816A SE 9402816 D0 SE9402816 D0 SE 9402816D0
Authority
SE
Sweden
Prior art keywords
pct
nerve head
drug
sec
meams
Prior art date
Application number
SE9402816A
Other languages
English (en)
Swedish (sv)
Inventor
Johan Stjernschantz
Goeran Selen
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9402816A priority Critical patent/SE9402816D0/xx
Publication of SE9402816D0 publication Critical patent/SE9402816D0/xx
Priority to EP95930761A priority patent/EP0777483B1/de
Priority to AU34022/95A priority patent/AU3402295A/en
Priority to US08/793,043 priority patent/US5952378A/en
Priority to DK95930761T priority patent/DK0777483T3/da
Priority to AT95930761T priority patent/ATE238799T1/de
Priority to PCT/SE1995/000962 priority patent/WO1996005840A1/en
Priority to DE69530594T priority patent/DE69530594T2/de
Priority to JP8508010A priority patent/JPH10507743A/ja
Priority to ES95930761T priority patent/ES2199253T3/es
Priority to CA002198245A priority patent/CA2198245C/en
Priority to PT95930761T priority patent/PT777483E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE9402816A 1994-08-24 1994-08-24 Method and meams for drug administration SE9402816D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9402816A SE9402816D0 (sv) 1994-08-24 1994-08-24 Method and meams for drug administration
PT95930761T PT777483E (pt) 1994-08-24 1995-08-24 Metodos e meio para administrar farmacos
DK95930761T DK0777483T3 (da) 1994-08-24 1995-08-24 Fremgangsmåder og middel til lægemiddelindgivelse
AU34022/95A AU3402295A (en) 1994-08-24 1995-08-24 Methods and means for drug administration
US08/793,043 US5952378A (en) 1994-08-24 1995-08-24 Methods and means for drug administration
EP95930761A EP0777483B1 (de) 1994-08-24 1995-08-24 Verfahren und mittel zur arzneistoffverabreichung
AT95930761T ATE238799T1 (de) 1994-08-24 1995-08-24 Verfahren und mittel zur arzneistoffverabreichung
PCT/SE1995/000962 WO1996005840A1 (en) 1994-08-24 1995-08-24 Methods and means for drug administration
DE69530594T DE69530594T2 (de) 1994-08-24 1995-08-24 Verfahren und mittel zur arzneistoffverabreichung
JP8508010A JPH10507743A (ja) 1994-08-24 1995-08-24 薬剤投与のための方法と手段
ES95930761T ES2199253T3 (es) 1994-08-24 1995-08-24 Procedimientos y medios para la administracion de farmacos.
CA002198245A CA2198245C (en) 1994-08-24 1995-08-24 Methods and means for drug administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402816A SE9402816D0 (sv) 1994-08-24 1994-08-24 Method and meams for drug administration

Publications (1)

Publication Number Publication Date
SE9402816D0 true SE9402816D0 (sv) 1994-08-24

Family

ID=20395002

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402816A SE9402816D0 (sv) 1994-08-24 1994-08-24 Method and meams for drug administration

Country Status (12)

Country Link
US (1) US5952378A (de)
EP (1) EP0777483B1 (de)
JP (1) JPH10507743A (de)
AT (1) ATE238799T1 (de)
AU (1) AU3402295A (de)
CA (1) CA2198245C (de)
DE (1) DE69530594T2 (de)
DK (1) DK0777483T3 (de)
ES (1) ES2199253T3 (de)
PT (1) PT777483E (de)
SE (1) SE9402816D0 (de)
WO (1) WO1996005840A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
US7708711B2 (en) 2000-04-14 2010-05-04 Glaukos Corporation Ocular implant with therapeutic agents and methods thereof
AU2002258754B2 (en) 2001-04-07 2006-08-17 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
EP1418903A2 (de) * 2001-04-23 2004-05-19 The Board of Regents of the University of Texas System Prostanoide verstärken die okulare penetration von arzneimitteln
US7678065B2 (en) 2001-05-02 2010-03-16 Glaukos Corporation Implant with intraocular pressure sensor for glaucoma treatment
WO2002089699A2 (en) 2001-05-03 2002-11-14 Glaukos Corporation Medical device and methods of use for glaucoma treatment
EP1410808A4 (de) * 2001-07-02 2009-07-29 Santen Pharmaceutical Co Ltd Mittel zum schutz des sehnervs mit alpha-1-rezeptor-blocker als wirkstoff
US7331984B2 (en) 2001-08-28 2008-02-19 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
US7163543B2 (en) * 2001-11-08 2007-01-16 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
CN1620325A (zh) 2001-12-14 2005-05-25 艾尔科公司 治疗眼睛障碍和疾病的超氧化物歧化酶模拟物
US20030113270A1 (en) * 2001-12-14 2003-06-19 Clark Abbot F. Vasoactive intestinal peptides for glaucomatous retinopathy
US7951155B2 (en) 2002-03-15 2011-05-31 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US9301875B2 (en) 2002-04-08 2016-04-05 Glaukos Corporation Ocular disorder treatment implants with multiple opening
EP1539066B1 (de) * 2002-09-17 2012-11-07 Iscience Surgical Corporation Gerät zur chirurgischen umleitung von wässrigen körperflüssigkeiten
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
CA2536874A1 (en) * 2003-09-05 2005-03-17 Novartis Ag Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives
AU2004305531B2 (en) * 2003-12-11 2009-11-26 Alcon, Inc. Superoxide dismutase mimics for the treatment of optic nerve and retinal damage
WO2005107664A2 (en) * 2004-04-29 2005-11-17 Iscience Interventional Corporation Apparatus and method for surgical enhancement of aqueous humor drainage
US8322350B2 (en) * 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
US7625927B2 (en) * 2006-02-27 2009-12-01 Alcon Research, Ltd. Method of treating glaucoma
AU2007319383A1 (en) 2006-11-10 2008-05-22 Glaukos Corporation Uveoscleral shunt and methods for implanting same
WO2009032273A1 (en) * 2007-09-05 2009-03-12 Teva Pharmaceutical Industries, Ltd. Method of treating glaucoma using rasagiline
US8425473B2 (en) 2009-01-23 2013-04-23 Iscience Interventional Corporation Subretinal access device
US20100191177A1 (en) * 2009-01-23 2010-07-29 Iscience Interventional Corporation Device for aspirating fluids
JP5342301B2 (ja) * 2009-03-30 2013-11-13 三菱重工業株式会社 太陽光集光受熱器
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
JP5937004B2 (ja) 2009-05-18 2016-06-22 ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 薬剤溶出眼内インプラント
EP2627292B1 (de) 2010-10-15 2018-10-10 Clearside Biomedical, Inc. Vorrichtung für okularen zugang
US9668915B2 (en) 2010-11-24 2017-06-06 Dose Medical Corporation Drug eluting ocular implant
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
EP4193907B1 (de) 2011-09-13 2026-04-15 Glaukos Corporation Intraokularer physiologischer sensor
KR102467714B1 (ko) 2012-11-08 2022-11-16 클리어사이드 바이오메디컬, 인코포레이드 인간 대상체에서 안구 질병을 치료하기 위한 방법 및 장치
US9730638B2 (en) 2013-03-13 2017-08-15 Glaukos Corporation Intraocular physiological sensor
AU2014259694B2 (en) 2013-05-03 2018-11-08 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
US10188550B2 (en) 2013-06-03 2019-01-29 Clearside Biomedical, Inc. Apparatus and methods for drug delivery using multiple reservoirs
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
US20150342875A1 (en) 2014-05-29 2015-12-03 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
WO2015196085A2 (en) 2014-06-20 2015-12-23 Clearside Biomedical, Inc. Variable diameter cannula and methods for controlling insertion depth for medicament delivery
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
WO2017139375A1 (en) 2016-02-10 2017-08-17 Clearside Biomedical, Inc. Ocular injection kit, packaging, and methods of use
US11318043B2 (en) 2016-04-20 2022-05-03 Dose Medical Corporation Bioresorbable ocular drug delivery device
WO2017192565A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0286903B2 (de) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes

Also Published As

Publication number Publication date
EP0777483B1 (de) 2003-05-02
PT777483E (pt) 2003-09-30
CA2198245C (en) 2003-06-17
CA2198245A1 (en) 1996-02-29
DK0777483T3 (da) 2003-08-25
AU3402295A (en) 1996-03-14
ES2199253T3 (es) 2004-02-16
JPH10507743A (ja) 1998-07-28
ATE238799T1 (de) 2003-05-15
WO1996005840A1 (en) 1996-02-29
US5952378A (en) 1999-09-14
DE69530594D1 (de) 2003-06-05
DE69530594T2 (de) 2004-03-18
EP0777483A1 (de) 1997-06-11

Similar Documents

Publication Publication Date Title
DK0777483T3 (da) Fremgangsmåder og middel til lægemiddelindgivelse
PT850068E (pt) Extracto lipidico com actividade anti-inflamatoria
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
IT1274879B (it) Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
ES2136624T3 (es) Implante biocompatible para regular la ovulacion en yeguas.
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE239474T1 (de) Verwendung von levobupivacain
AU7814498A (en) Multivalent (in ovo) avian vaccine
BR0211855A (pt) Medicamento e método para tratamento e melhoria da qualidade restauradora do sono
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
SE9403160D0 (sv) Method and means for prevention and treatment of secondary cataract
EE9700068A (et) Selegiliini kasutamine epileptiliste haiguste raviks
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
SE9101341D0 (sv) New medicinal use
EE200100122A (et) R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
AR001687A1 (es) Producto farmacéutico apropiado para el tratamiento parenteral de daños producidos por enfermedades isquemicas focales permanentes que comprende (s)-adenosil-l-metionina (SAMe)